US 8193339
Synthesis of β-nucleosides
granted A61PA61P31/12A61P35/00
Quick answer
US patent 8193339 (Synthesis of β-nucleosides) held by PHARMAESSENTIA CORPORATION expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PHARMAESSENTIA CORPORATION
- Grant date
- Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P31/12, A61P35/00